The diagnostic drug DaTscan ([123I]Ioflupane) is no longer a controlled substance and therefore not subject to any Controlled Substances Act controls, the Drug Enforcement Administration said in a Feb. 26 Federal Register notice on removing the drug from Part 1301 (81 Fed. Reg. 9763). Since 2014, handlers of DaTscan who were operating under authority of the U.S. Nuclear Regulatory... Read More